SCT Announces Partnership with Antibody Solutions at 2017 Antibody Engineering & Therapeutics Conference

Sunnyvale, Calif. (Dec. 4, 2017) – Antibody Solutions, a leader in discovery of therapeutic, biomarker and critical reagent antibodies, and Single Cell Technology, Inc. (SCT), a pioneer in single cell analysis technology, have launched a partnership that offers pharmaceutical researchers one-stop access to advanced single B-cell antibody discovery capabilities. The new Single B-Cell Antibody Discovery service…

Details

Breakthrough Demonstration of Single Cell Technology’s Antibody Discovery Process

San Jose, CA June 2, 2016 Single Cell Technology, Inc., (SCT) today announced their revolutionary antibody discovery technology correctly extracts the two DNA sequences of high affinity antibodies over 95% of the time. These results were confirmed when SCT’s antibodies were molecularly reconstructed by Lake Pharma, a leading contract research organization, and compared to an…

Details

Chair of the University of Pittsburgh Department of Immunology joins Single Cell Technology’s Scientific Advisory Board

San Jose, CA April 28, 2016 Single Cell Technology, Inc. (SCT) today announced the appointment of Mark J. Shlomchik, M.D., Ph.D. to its Scientific Advisory Board.  Dr. Shlomchik currently surves as the Chair of the Department of Immunology, School of Medicine, University of Pittsburgh.  Dr. Shlomchik received his medical and doctoral degrees from the University…

Details